All Posts:brain research
-
Veterans Study Suggests Two Subtypes of Gulf War Illness
WASHINGTON (December 12, 2019) — Brain imaging of veterans with Gulf War illness show varying abnormalities after moderate exercise that can be categorized into two distinct groups — an outcome that suggests a more complex illness that previously thought. Researchers at Georgetown University Medical Center, using functional magnetic resonance imaging (fMRI), have shown the Gulf […]
Category: News Release
-
Why Adults at Risk for Huntington’s Disease Choose Not to Learn if They Inherited Deadly Gene
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (May 16, 2019) — As many as 90 percent of individuals who have a parent with Huntington’s disease (HD) choose not to take a gene test that reveals if they will also develop the fatal disorder — and a new study details the reasons why. Understanding the “why” matters as new […]
Category: News Release
-
Impacted by Parkinson’s Disease, Three Couples Plan to Leave a Lasting Legacy to Support Research
(April 26, 2019) — When someone is diagnosed with an incurable, life-changing disease like Parkinson’s, they usually have many questions about how it will affect their life and what can be done to manage it. Unfortunately, many people who have Parkinson’s symptoms don’t get those answers until they are fortunate enough to see a doctor […]
Category: GUMC Stories
-
Researchers Decode How Cancer Drug Works in Brains of Parkinson’s Disease Patients
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 12, 2019) — Laboratory analysis from the first arm of a phase II clinical trial testing the use of nilotinib in patients with Parkinson’s disease demonstrates precisely how the agent increases levels of dopamine in the brains of study participants, says a research team at Georgetown University Medical Center. Symptoms […]
Category: News Release
-
Doctors Speak Out Panelists on the Progress and Promise of Huntington’s Disease Research
A recent Doctors Speak Out event highlighted the progress scientists have made toward understanding Huntington’s disease, the promise of recent research developments, and the contributions of the Georgetown Huntington’s Disease Care, Education and Research Center (HDCERC).
Category: GUMC Stories
-
Use of Electrical Brain Stimulation to Foster Creativity Has Sweeping Implications
What is creativity, and can it be enhanced — safely — in a person who needs a boost of imagination? In a newly published article, Georgetown experts debate the growing use of electrical devices that stimulate brain tissue to improve various forms of creative cognition.
Category: News Release
-
Georgetown Clinical Trial Testing Nilotinib in Alzheimer’s Disease Begins
A clinical trial to examine the effect of nilotinib on clinical outcomes and biomarkers in people with mild to moderate Alzheimer’s disease has opened at Georgetown University Medical Center (GUMC).
Category: News Release
-
Resveratrol Impacts Alzheimer’s Disease Biomarker
WASHINGTON — The largest nationwide clinical trial to study high-dose resveratrol long-term in people with mild to moderate Alzheimer’s disease found that a biomarker that declines when the disease progresses was stabilized in people who took the purified form of resveratrol.
Category: News Release
-
Patients Drive Support Of Parkinson’s Fellowship Program
March 2, 2015 — Twelve years ago, Rick Schena, a United Airlines pilot, felt something amiss in the body he has always been so in tune with — the onset of tremors, some rigidity, and issues with processing vision. Six years ago he was diagnosed with Parkinson’s. This was devastating to the speed junkie who […]
Category: GUMC Stories
-
GUMC Announces the George Bergeron Endowed Professorship in Neuroscience
Georgetown University Medical Center (GUMC) announces the establishment of the George Bergeron Endowed Professorship in Neuroscience. The $1.25 million gift will support an exceptional scientist and launch the Center for Brain Plasticity and Recovery.
Category: News Release